About Evolvus Biotech Private Limited
Data last updated:
Evolvus Biotech Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 19 December 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24231PN2001PTC016611.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sharvari Aniket Ausekar and Aniket Suresh Ausekar.
Its last annual general meeting (AGM) was held on 07 April 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 997/Pn – 15 Satsang Society Navi Peth, Pune, Maharashtra, India – 411030.
As per the financials filed for FY 2026, the company reported a revenue of ₹12 Lakh. For the same year it recorded a net profit of ₹1.17 Lakh (net margin 9.7%) and EBITDA of ₹1.31 Lakh (EBITDA margin 11%). Revenue has declined at a compounded annual rate (CAGR) of 313% over three years and 8% over five years.
Court records list 2 cases involving the company, including 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website evolvus.com.
Company details
Contact details
Evolvus Biotech Private Limited's registered office is in Pune, Maharashtra. Its website is evolvus.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address997/Pn – 15 Satsang Society Navi Peth, Pune, Maharashtra, India – 411030
- IndustryLife Sciences, Biotechnology
To see the full contact details of Evolvus Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Evolvus Biotech Private Limited
FY 2025 filings availableEvolvus Biotech Private Limited reported revenue of ₹12 Lakh for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 8% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.31 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.17 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11% | ||||
| Net Profit Margin | 9.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Evolvus Biotech Private Limited, buy the company report.
Board of directors of Evolvus Biotech Private Limited
Evolvus Biotech has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sharvari Aniket Ausekar | Director | 04 Apr 2004 | 22 Years 6 Months | Current |
| Aniket Suresh Ausekar | Director | 19 Dec 2001 | 24 Years 10 Months | Current |
| Salil Vinayak Karmarkar Also directs: Evolvus Technologies Private Limited | Additional Director | 24 May 2025 | 1 Years 4 Months | Current |
Auditor
Evolvus Biotech Private Limited is audited by TEJAS A. JOSHI & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| TEJAS A. JOSHI & CO. | FY 2017 | 130077W |
Shareholding
The shareholding of Evolvus Biotech Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Evolvus Biotech Private Limited, buy the company report.
Legal cases
Evolvus Biotech Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (1 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Pune, Maharashtra | Civil suit | Filed against the company by Govt.Of India----Roc---- | Disposed |
To see the full case history of Evolvus Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Evolvus Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Evolvus Biotech Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Evolvus Biotech Private Limited has 3 board changes on record since 2001: 3 appointments. The latest: Salil Vinayak Karmarkar was appointed as Additional Director on 24 May 2025.
Frequently asked questions
Evolvus Biotech is an active private limited company based in Pune, Maharashtra, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 19 December 2001 (25+ years old) and is registered under CIN U24231PN2001PTC016611.
Evolvus Biotech has 3 current directors:
- Sharvari Aniket Ausekar - Director
- Aniket Suresh Ausekar - Director
- Salil Vinayak Karmarkar - Additional Director
The latest financial statements of Evolvus Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 07 April 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Evolvus Biotech is U24231PN2001PTC016611. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Evolvus Biotech has 2 court cases on record: 2 filed against it.
Evolvus Biotech was incorporated on 19 December 2001, making it 25+ years old. It is registered with the Registrar of Companies, Pune.
Salil Vinayak Karmarkar was appointed as Additional Director on 24 May 2025. Sharvari Aniket Ausekar was appointed as Director on 04 Apr 2004. Aniket Suresh Ausekar was appointed as Director on 19 Dec 2001.
Evolvus Biotech can be reached through the website evolvus.com. Its registered office is in Pune, Maharashtra, India.
The registered office of Evolvus Biotech is at 997Pn – 15 Satsang Society Navi Peth, Pune, Maharashtra, India – 411030.
Evolvus Biotech operates in the life sciences industry, in the biotechnology segment.